SynthesisFrontiers in endocrinology2024

Risk of bone fracture by using dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus: a network meta-analysis of population-based cohort studies.

Mohamed E A Mostafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.